| BAC | Bioactive compounds |
| IBD | Inflammatory bowel disease |
| CD | Crohn’s disease |
| UC | Ulcerative colitis |
| TNF-α | Tumor necrosis factor-alpha |
| IL-1β | Interleukin-1 beta |
| IL-6 | Interleukin-6 |
| NF-κB | Nuclear factor kappa B |
| ROS | Reactive oxygen species |
| RNS | Reactive nitrogen species |
| SOD | Superoxide dismutase |
| GPx | Glutathione peroxidase |
| PLA2 | Phospholipase A2 |
| COX | Cyclooxygenase |
| LOX | Lipoxygenase |
| EGFRs | Epidermal growth factor receptors |
| EAC | Ehrlich ascites carcinoma |
| AgNORs | Argyrophilic nucleolar organizer regions |
| EGCG | Epigallocatechin-3-gallate |
| Foxp3 | Forkhead Box P3 |
| IL-10 | Interleukin-10 |
| PAL | Phenylalanine ammonia-lyase |
| IMIDs | immune-mediated inflammatory diseases |
| CRP | C-reactive protein |
| ESR | Erythrocyte sedimentation rate |
| MAPK | Mitogen-activated protein kinase |
| ERK | Extracellular signal-regulated kinase |
| NOS | Nitric oxide synthase |
| COX-2 | cyclooxygenase-2 |
| LPS | Lipopolysaccharide |
| STAT | Signal transducer and transcription activator |
| IFN)-α | Interferon-α |
| GM-CSF | Granulocyte-macrophage colony-stimulating factor |
| EPO | Erythropoietin |
| TYK2 | Tyrosine Kinase 2 |
| 6-MP | 6-Mercaptopurine |
| RSV | Resveratrol |
| ET | Ellagitannin |
| PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
| PICOs | Population Intervention Comparison Outcome Study design |
| ARF | Anthocyanin-rich fraction |
| 5-ASA | 5-aminosalicylic acid |
| TNBS | Trinitro benzenesulfonic acid |
| DSS | Dextran sodium sulfate |
| DAI | Disease activity index |
| ARBE | Anthocyanin-rich bilberry extract |
| MCP-1 | Monocyte chemoattractant protein-1 |
| SCFAs | Short-chain fatty acids |